In untreated AD mice, SOD activity significantly decreased in ageing animals more evidently at intermediate-to-late time points, and SLAB51 treatment partially helped recovery basal levels of 8-week-old untreated AD mice. This evidence concerns the gene SOD1 and Alzheimer disease.